Portside Wealth Group, LLC Argenx Se Transaction History
Portside Wealth Group, LLC
- $586 Billion
- Q3 2024
A detailed history of Portside Wealth Group, LLC transactions in Argenx Se stock. As of the latest transaction made, Portside Wealth Group, LLC holds 491 shares of ARGX stock, worth $307,518. This represents 0.05% of its overall portfolio holdings.
Number of Shares
491
Previous 496
1.01%
Holding current value
$307,518
Previous $213 Million
24.78%
% of portfolio
0.05%
Previous 0.04%
Shares
5 transactions
Others Institutions Holding ARGX
# of Institutions
400Shares Held
30.9MCall Options Held
376KPut Options Held
489K-
Price T Rowe Associates Inc Baltimore, MD5.82MShares$3.65 Billion0.36% of portfolio
-
Artisan Partners Limited Partnership Milwaukee, WI3.51MShares$2.2 Billion2.99% of portfolio
-
Janus Henderson Group PLC London, X02.48MShares$1.55 Billion0.72% of portfolio
-
Capital World Investors Los Angeles, CA1.7MShares$1.06 Billion0.15% of portfolio
-
Avoro Capital Advisors LLC New York, NY1.24MShares$776 Million10.11% of portfolio
About ARGENX SE
- Ticker ARGX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 55,323,800
- Market Cap $34.6B
- Description
- argenx SE, a biotechnology company, focuses on developing various therapies for the treatment of autoimmune diseases in the United States, the Netherlands, Belgium, Japan, Switzerland, Germany and France. Its lead product candidate is efgartigimod for the treatment of patients with myasthenia gravis, immune thrombocytopenia, pemphigus vulgaris, ...